Shilpa Medicare Credit Rating

Shilpa Medicare Board Meeting Date

Shilpa Medicare's board meeting is scheduled for 5 November 2026 to approve Q2 and H1 unaudited financial results. The trading window remains closed until 7 November 2026.

Shilpa Medicare Business Update

Shilpa Medicare Limited’s Unit 4 in Jadcherla received GMP certification from AGES, Austria, following a successful inspection. This milestone enables operations for European and global markets.

Shilpa Medicare Other Announcement

Shilpa Medicare Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.

Shilpa Medicare Other Announcement

Shilpa Medicare Ltd KMP Alpesh Maheshkumar Dalal sold 4,000 equity shares via market sale. The transaction was valued at Rs.0.42 Crore and executed on the NSE.

Value

₹0.42 Cr

Shilpa Medicare Share Pledge

The company's promoters reported the release of encumbrance on 30,00,000 equity shares held by them. This reduction in pledged shares signals a change in promoter leverage.

Shilpa Medicare Other Announcement

Shilpa Medicare received a 'Crisil ESG 59' rating from CRISIL ESG Ratings for FY2026. This is a routine regulatory disclosure under Regulation 30 with no financial implications.

Subros Credit Rating

ICRA assigned or reaffirmed Subros's bank facility ratings, with total rated facilities rising from Rs.305 Crore to Rs.370 Crore. The long-term term loan rating is [ICRA]AA (Stable), raised to Rs.140 Crore from Rs.40 Crore.

Capital India Finance Credit Rating

Capital India Finance received a new ACUITE A- long-term rating with Stable outlook for its proposed NCDs. Acuite assigned it on 2 November 2026.

Deccan Cements Credit Rating

Infomerics withdrew its rating on Deccan Cements' proposed NCD issue after the proposal was dropped. The earlier August 2026 action was a downgrade to IVR BB+/Negative.

Oriental Rail Infrastructure Credit Rating

Oriental Rail Infrastructure received an India Ratings assignment of IND BBB+/Stable on its Rs.35 Crore bank loan facilities. The rating reflects the company's current creditworthiness.

Nureca Credit Rating

CRISIL assigned Nureca Limited ratings of BB+/Stable (long-term) and A4+ (short-term) on bank facilities totalling Rs.80 Crore. The outlook is Stable.

Shreeji Global FMCG Credit Rating

Infomerics affirmed Shreeji Global FMCG's ratings at IVR BBB/Stable (long-term) and IVR A3+ (short-term). Rated bank facilities were revised upward, per the enclosed rating letter.